Worried about symptoms? Choose one to start our AI Symptom Checker.
There is a lump
Lumps under skin
Cysts under skin
There is a nodule in the groin
Scalp with lumps
There is a nodule on the head
Lump on cheek
Not seeing your symptoms? No worries!
By starting the symptom checker, you agree to the Privacy Policy and Terms of Use
With a free 3-min Sebaceous Gland Carcinoma quiz, powered by Ubie's AI and doctors, find possible causes of your symptoms.
This questionnaire is customized to your situation and symptoms, including the following personal information:
Biological Sex - helps us provide relevant suggestions for male vs. female conditions.
Age - adjusts our guidance based on any age-related health factors.
History - considers past illnesses, surgeries, family history, and lifestyle choices.
Your symptoms
Our AI
Your report
Your personal report will tell you
✔ When to see a doctor
✔︎ What causes your symptoms
✔︎ Treatment information etc.
Sebaceous carcinoma is an uncommon cancer that starts in the sebaceous gland, the oil gland in the skin. It typically affects the eyelids and begins as a lump or skin thickening. Common causes include exposure to radiation, a genetic condition called Muir Torré syndrome, or a weakened immune system.
The treatment for sebaceous gland carcinoma is complete surgical removal.
Reviewed By:
Robin Schoenthaler, MD (Oncology)
Board certified radiation oncologist with over 30 years experience treating cancer patients. Senior physician advisor for expert medical options in adult oncology. Published award-winning essayist on medical and health issues and more.
Yukiko Ueda, MD (Dermatology)
Dr. Ueda graduated from the Niigata University School of Medicine and trained at the University of Tokyo Medical School. She is currently a clinical assistant professor at the Department of Dermatology, Jichi Medical University, and holds several posts in the dermatology departments at Kyoto Prefectural University of Medicine, Komagome Hospital, University of Tokyo, and the Medical Center of Japan Red Cross Society.
Content updated on Mar 31, 2024
Following the Medical Content Editorial Policy
Was this page helpful?
Kaliki S, Morawala A, Krishnamurthy A, Divya Jajapuram S, Mohamed A. Sebaceous Gland Carcinoma: Influence of Age at Presentation on Outcomes. Ophthalmic Plast Reconstr Surg. 2021 Jul-Aug 01;37(4):341-345. doi: 10.1097/IOP.0000000000001863. PMID: 33237664.
https://journals.lww.com/op-rs/Abstract/2021/07000/Sebaceous_Gland_Carcinoma__Influence_of_Age_at.7.aspxMcGrath LA, Currie ZI, Mudhar HS, Tan JHY, Salvi SM. Management of recurrent sebaceous gland carcinoma. Eye (Lond). 2020 Sep;34(9):1685-1692. doi: 10.1038/s41433-019-0756-9. Epub 2020 Jan 2. PMID: 31896805; PMCID: PMC7608101.
https://www.nature.com/articles/s41433-019-0756-9Reviewed By:
Robin Schoenthaler, MD (Oncology)
Board certified radiation oncologist with over 30 years experience treating cancer patients. Senior physician advisor for expert medical options in adult oncology. Published award-winning essayist on medical and health issues and more.
Yukiko Ueda, MD (Dermatology)
Dr. Ueda graduated from the Niigata University School of Medicine and trained at the University of Tokyo Medical School. She is currently a clinical assistant professor at the Department of Dermatology, Jichi Medical University, and holds several posts in the dermatology departments at Kyoto Prefectural University of Medicine, Komagome Hospital, University of Tokyo, and the Medical Center of Japan Red Cross Society.
Our symptom checker AI is continuously refined with input from experienced physicians, empowering them to make more accurate diagnoses.
“World’s Best Digital
Health Companies”
Newsweek 2024
“Best With AI”
Google Play Best of 2023
“Best in Class”
Digital Health Awards 2023 (Quarterfinalist)
Which is the best Symptom Checker?
Ubie’s symptom checker demonstrated a Top-10 hit accuracy of 71.6%, surpassing the performance of several leading symptom checkers in the market, which averaged around 60% accuracy in similar assessments.
Link to full study:
https://www.medrxiv.org/content/10.1101/2024.08.29.24312810v1